Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders A F Sima

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Annals of Neurology|September 30, 2004
Diabetes underlies common neurological disordersAnders A F Sima
CNS Drugs|September 26, 2007
Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical dataAnders A F Sima
Journal of the Neurological Sciences|May 14, 2004
Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptideAnders A F Sima
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The heterogeneity of diabetic neuropathyAnders A F Sima
Acta Diabetologica|August 28, 2010
Encephalopathies: the emerging diabetic complicationsAnders A F Sima
Current Opinion in Investigational Drugs (London, England : 2000)|April 22, 2006
Pathological mechanisms involved in diabetic neuropathy: can we slow the process?Anders A F Sima
Expert Opinion on Investigational Drugs|August 29, 2003
C-peptide and diabetic neuropathyAnders A F Sima
The Review of Diabetic Studies : RDS|May 12, 2007
Will C-peptide substitution make a difference in combating complications in insulin-deficient diabetes?Anders A F Sima
Handbook of Clinical Neurology|November 21, 2014
Mechanisms of diabetic neuropathy: axon dysfunctionAnders A F Sima, Weixian Zhang
Current Drug Targets|January 29, 2008
Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?Anders A F Sima, Hideki Kamiya
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Annals of Neurology|September 30, 2004
Diabetes underlies common neurological disordersAnders A F Sima
CNS Drugs|September 26, 2007
Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical dataAnders A F Sima
Journal of the Neurological Sciences|May 14, 2004
Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptideAnders A F Sima
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The heterogeneity of diabetic neuropathyAnders A F Sima
Acta Diabetologica|August 28, 2010
Encephalopathies: the emerging diabetic complicationsAnders A F Sima
Current Opinion in Investigational Drugs (London, England : 2000)|April 22, 2006
Pathological mechanisms involved in diabetic neuropathy: can we slow the process?Anders A F Sima
Expert Opinion on Investigational Drugs|August 29, 2003
C-peptide and diabetic neuropathyAnders A F Sima
The Review of Diabetic Studies : RDS|May 12, 2007
Will C-peptide substitution make a difference in combating complications in insulin-deficient diabetes?Anders A F Sima
Handbook of Clinical Neurology|November 21, 2014
Mechanisms of diabetic neuropathy: axon dysfunctionAnders A F Sima, Weixian Zhang
Current Drug Targets|January 29, 2008
Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?Anders A F Sima, Hideki Kamiya
Pageof 6